(Last Updated On: October 26, 2018)

Authors: Imee P. Rajagukguk M.D., Maria Teresita Gabriel M.D. FPDS and Reynaldo Ugalde M.D. FPDS

Abstract

Background: Cutaneous manifestations are common clinical findings among HIV-positive patients and may be the first presentation of HIV disease. The causes are bacteria, viruses, fungi and other non-infectious agents. In the Philippines, data on prevalence of skin diseases in HIV and association with CD4 counts is limited.

Objective: To determine the cutaneous manifestations seen in HIV-positive patients and their association with the degree of immunosuppression based on CD4 count.

Methods: A retrospective chart review study on skin disorders of HIV-positive outpatients in the Department of Dermatology at the Research Institute for Tropical Medicine, Philippines from January 2004 to December 2013 was conducted. Demographic data, most common cutaneous manifestations, and its correlation with CD4 counts were determined.

Results: Six-hundred-fifty-five patients (male: female, 11:1) were enrolled in the study. Majority of patients were males (90.7%) and between18-29 years old (53.3%) with a mean age of 30.39 years (±7.9). Patients were mostly college graduates (75.6%) and employed (82.70%). The most common cutaneous manifestations were viral skin infections (33.6%), non-infective dermatosis (30.4%), bacterial skin infections (20.6%), and fungal skin infections (11.6%). A CD4 count <200/mm3 was significantly associated with a higher number of skin disorders (p=0.000), development of viral skin infections [relative risk (RR), 5.1; 95% confidence interval (CI) 3.36–7.71; p = 0.000], bacterial skin infections [RR, 3.2; 95% CI 2.02- 5.23; p = 0.000], and fungal skin infections [RR, 16.8; 95% CI 6–42.5; p = 0.000].

Conclusion: The skin lesions associated with HIV-positive patients are protean, but viral, bacterial, and fungal manifestations were most commonly observed. The skin lesions were highly associated with immunosuppression based on diminishing CD4 counts. In resource-poor settings where diagnostic facilities are limited, the presence of these cutaneous lesions should alert the dermatologist to the progression of HIV disease.

 

Citation

Rajagukguk, I, Gabriel, MT & Ugalde, R. (2017). Cutaneous manifestations of patients with HIV infection at the Research Institute for Tropical Medicine Dermatology Outpatient Department: A 10-year review. Journal of the Philippine Dermatological Society, 26(2), 41-46.

 

Keywords

cutaneous manifestation, skin disease, HIV, CD4 count

 

  1. UNAIDS and World Health Organization. AIDS Epidemic Update. Geneva, Switzerland; 2010.
  2. Department of Health. HIV-AIDS and ART Registry of the Philippines. Sta. Cruz, Manila: National HIV/AIDS & STI Surveillance and Strategic Information Unit; 2017 May.
  3. Graeme JS, Irvine SS, Scott M, Kelleher AD, Marriott DJE, McKnight I, et al. Strategies of care in managing HIV. Med J Aust. 1996;164(2):99-104.
  4. McNaghten AD, Hanson L, Nakashima AK, Swerdlow DL. Incidence of AIDS-defining opportunistic infections in the US may be leveling from 1998-1999. Meet. Infect. Dis. Soc. Am. 2001 Oct 25-28; San Francisco; 2008. p. 751.
  5. Penneys NS. Skin manifestations of AIDS. 2nd London: CRC Press;1995.
  6. Bustamante JB, Montinola FL. Aids-related Kaposi’s sarcoma. Makati Medical Center Proceedings. 1993;7:68-72.
  7. Peralejo BM, Santiago EG., Medel RB. Dermatologic disorders associated with HIV infection in Filipinos. J Phil Dermatol Soc. 1995 May;4(1):27-36.
  8. Muhammad B, Eligius L, Mugusi F, Aris E, Chale S, Magao P, et al. The prevalence and pattern of skin diseases in relation to CD4 counts among HIV-infected police officers in Dar es Salaam. Trop Doct. 2003 Jan;33(1):44-8.
  9. Phillips AM, Jones AG, Osmond DH, Pollack LM, Catania JA, Martin JN, et al. Awareness of Kaposi sarcoma-associated herpesvirus among men who have sex with men. Sex Transm Dis. 2008 July;35(12):1011–4.
  10. Pera M, Sugrañes G, Ordi J, Trias M. Association between human papillomavirus infection, premalignant lesions of anal cancer, and the human immunodeficiency virus: prospective study on subjects with condylomata acuminate. Med Clin (Barc). 1999 Jun 12;113(1):13-4.
  11. Piketty C, Darragh TM, Da Costa M, Bruneval P, Heard I, Kazatchkine MD, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med. 2003 Mar 18;138(6): 453-9.
  12. Kim TG1, Lee KH, Oh SH. Skin disorders in Korean patients infected with human immunodeficiency virus and their association with a CD4 lymphocyte count: a preliminary study. J Eur Acad Dermatol Venereol. 2010 Dec; 24(12):1476-80.
  13. Kang SH, Lee D, Park JH, Kang MS, Cho SH, Park SW. Scrotal eczema-like lesion of secondary syphilis in an HIV-positive patient. Acta Derm Venereol. 2005;85(6): 536-7.
  14. Kaplan MH, Sadick N, McNutt NS, Meltzer M, Sarngadharan MG, Pahwa S. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol. 1987;16:485–506.
  15. Glover RA, Piaquadio DJ, Kern S, Cockerell CJ. An unusual presentation of secondary syphilis in a patient with human immunodeficiency virus infection. A case report and review of the literature. Arch Dermatol. 1992;128:530–534.
  16. Reichart PA. Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi’s sarcoma. Med Microbiol Immunol. 2003 Aug;192(3):165-9.
  17. Klein RS, Harris CA, Butkus-Small C, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the Acquired Immunodeficiency Syndrome. N Engl J Med. 1984;311:354-358.
  18. Bason MM, Berger TG, Nesbitt LT Jr. Pruritic papular eruption of HIV-disease. Int J Dermatol. 1993;32:784-9.
  19. Liautaud B, Pape JW, DeHovitz JA, Thomas F, LaRoche AC, Verdier RI, et al. Pruritic skin lesions: A common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol. 1989;125:629-32.
  20. Rosatelli JB, Machado AA, Roselino AM. Dermatoses among Brazilian HIV-positive patients: Correlation with the evolutionary phases of AIDS. Int J Dermatol. 1997;36:729-34.
  21. Annam V, Yelikar B R, Inamadar AC, Palit A. Histopathological study of pruritic papular eruptions in HIV-infected patients in relationship with CD4, CD8 counts. Indian J Pathol Microbiol. 2009;52:321-4.
  22. Nnoruka EN1, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Int J Dermatol. 2007 Oct;46 Suppl 2:14-8.
  23. Goh BK1, Chan RK, Sen P, Theng CT, Tan HH, Wu YJ, et al. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts. Int J Dermatol. 2007 Jul;46(7):695-9.
  24. Rane SR, Agrawal PB, Kadgi NV, Jadhav MV, Puranik SC. Histopathological study of cutaneous manifestations in HIV and AIDS patients. Int J Dermatol. 2014 Jun;53(6):746-51.
  25. Chawhan MS., Bhat DM., Solanke SM., Dermatological manifestations in human immunodeficiency virus infected patients: Morphological spectrum with CD4 correlation. Indian J Sex Dis. Transm. 2013-Jul-Dec;34(2)89-94.
  26. Kane A, Niang S, Kébé M, Ly F, Diallo M, Dieng MT, et al. Cutaneous side effects of antiretroviral drugs. Mali Med. 2007;22(1):22-5.

More Articles